449.71USD-0.14%Mkt Cap: 12.89B USDP/E: 28.41Last update: 2026-06-01
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting…
Industry Peers
Diagnostics & Research183.26BUSDP/E 27.1
127.46BUSDP/E 35.0
45.09BUSDP/E 42.1
38.48BUSDP/E 27.4
37.00BUSDP/E 47.9
34.66BCHFP/E 38.1
31.51BUSD—
31.45BUSDP/E 23.4
Indicators:|
Key Statistics
Company
Market Cap12.89B USD
Enterprise Value12.26B USD
Revenue (TTM)2.68B USD
Gross Profit760.62M USD
Net Income (TTM)451.12M USD
Revenue/Share94.44 USD
Last Price449.71 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6.3K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS58506Q1094
Valuation
P/E (Trailing)28.41
P/E (Forward)24.09
PEG2.76
EV/EBITDA20.75
EV/Revenue4.58
P/S4.77
P/B21.34
EPS (TTM)15.87
EPS (Forward)18.56
52W Range
291.2847% of range628.92
52W High628.92 USD
52W Low291.28 USD
Profitability
Gross Margin30.06%
Oper. Margin20.03%
EBITDA Margin22.07%
Profit Margin17.83%
ROE98.27%
ROA22.84%
Growth
Revenue Growth26.50%
Earnings Growth16.60%
Cash Flow & Leverage
Operating CF713.22M USD
CapEx (TTM)31.36M USD
FCF Margin18.32%
FCF Yield3.81%
Net Debt-506.59M USD
Net Debt/EBITDA-0.86
Balance Sheet
Debt/Equity0.25
Current Ratio0.85
Quick Ratio0.78
Book Value/Sh20.95 USD
Cash/Share22.85 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)442.83 USD
Target Range329.00 USD – 495.00 USD
# Analysts12
Ownership
Shares Out.28.56M
Float23.00M
Insiders19.42%
Institutions88.84%
Short Interest
Short Ratio3.9d
Short % Float8.27%
Short % Out.6.67%
Shares Short1.90M
Short (prev mo.)1.35M
Technical
SMA 50455.69 (-1.3%)
SMA 200512.94 (-12.3%)
Beta1.19
S&P 52W Chg27.94%
Avg Vol (30d)407.55K
Avg Vol (10d)305.20K
Technical Indicators
RSI (14)57.2
MACD-3.8689
MACD Signal-9.0489
MACD Hist.+5.1800
BB Upper444.19 USD
BB Middle426.00 USD
BB Lower407.81 USD
BB Width8.54%
ATR (14)16.38 USD
Vol Ratio (20d)0.39x